Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Net Margin (2016 - 2025)

Veracyte (VCYT) has disclosed Net Margin for 14 consecutive years, with 29.29% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 2496.0% to 29.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.83% through Dec 2025, up 742.0% year-over-year, with the annual reading at 12.83% for FY2025, 742.0% up from the prior year.
  • Net Margin hit 29.29% in Q4 2025 for Veracyte, up from 14.48% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 29.29% in Q4 2025 to a low of 114.06% in Q1 2021.
  • Historically, Net Margin has averaged 11.55% across 5 years, with a median of 9.55% in 2023.
  • Biggest five-year swings in Net Margin: tumbled -7641bps in 2021 and later soared 9272bps in 2022.
  • Year by year, Net Margin stood at 15.54% in 2021, then soared by 69bps to 4.75% in 2022, then crashed by -506bps to 28.81% in 2023, then surged by 115bps to 4.33% in 2024, then skyrocketed by 576bps to 29.29% in 2025.
  • Business Quant data shows Net Margin for VCYT at 29.29% in Q4 2025, 14.48% in Q3 2025, and 0.73% in Q2 2025.